Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|June 7, 2007
Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments?L Calabrò, A M Di Giacomo, M Altomonte, et al.
Cell Host & Microbe|October 22, 2013
HIV-1 Vif adaptation to human APOBEC3H haplotypesMarcel Ooms, Bonnie Brayton, Michael Letko, et al.
La Medicina Del Lavoro|February 7, 2006
Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VIIth Meeting of the International Mesothelioma Interest GroupC Porta, A Ardizzoni, G Gaudino, et al.
Minerva Anestesiologica|September 1, 1994
[Changes in immune status due to anesthesia and surgical intervention. The role of thymopentin and interleukins]C Launo, R De Grandi, C Augeri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1988
Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant MeM 50-10M Maio, B Gulwani, S Tombesi, et al.
Blood|August 15, 1990
Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disordersM Maio, A Pinto, A Carbone, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2012
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study)C Lebbe, P Lorigan, P Ascierto, et al.
ESMO Open|March 19, 2022
Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancersJ Tabernero, F Andre, J-Y Blay, et al.
Human Gene Therapy|October 20, 1996
Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cellsF Arienti, J Sulé-Suso, F Belli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma modelE Fonsatti, A P Jekunen, K J Kairemo, et al.
Pageof 9